chicagoest - The content of the first paragraph of your post is exactly why I have never thought that Hepalink was ever a choice as a potential buyer of RVX. The shear size of the opportunity for ABL is so massive that a marketing machine would be needed in order to capture the potential. Building that out is long and expensive. Looking at all of the companies named in the last sentence of that paragraph gives us a list of potential partners or buyers for RVX as well...plus a few more.

tada